New ESMO tumour DNA scale helps match patients with cancer to optimal targeted medicines
A new scale for tumour DNA mutations which will simplify and standardise choices for targeted cancer treatment has been agreed by leading cancer specialists in Europe and North America, according to the announcement the European…